Legal Representation
Attorney
Laila Wolfgram
USPTO Deadlines
Next Deadline
755 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-24)
Due Date
August 24, 2027
Grace Period Ends
February 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 20, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 24, 2021 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Jul 16, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 8, 2021 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Jul 8, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 8, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 8, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 8, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 16, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jun 12, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 11, 2021 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jun 11, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 6, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 6, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 6, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 9, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 8, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 4, 2021 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Feb 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 3, 2021 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Feb 3, 2021 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jan 4, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 4, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jan 4, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 4, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 9, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Dec 9, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 28, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 28, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 28, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 27, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 26, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 26, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 25, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 18, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2019 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 23, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 16, 2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Sep 6, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 5, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 20, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biological tissue in the nature of umbilical cord, afterbirth and amniotic membrane tissue for use in oral surgery, namely, umbilical cord tissue, afterbirth tissue and amniotic membrane by itself, or separated into either of its component parts, amnion and chorion, and any part of the foregoing tissues in combination with either a natural or synthetic biodegradable polymer for use in perioplastic surgery, mucogingival surgery, reconstruction of the oral mucosa and/or other related soft tissue regeneration procedures, guided tissue regeneration, guided bone regenerations, or other procedures related to new bone formation in the mandible and maxilla; Human allograft tissue
First Use Anywhere:
Nov 30, 2016
First Use in Commerce:
Dec 2, 2016
Additional Information
Design Mark
The mark consists of a three-dimensional configuration comprising a smile design imprinted into a square of biological tissue. The matter shown by the dotted lines is not a part of the mark and serves only to show the position of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005